Results 221 to 230 of about 587,195 (299)
Modelling the Variability in Immunity Build-Up and Waning Following RNA-Based Vaccination. [PDF]
Magalang J, Krueger T, Galle J.
europepmc +1 more source
Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease
RNA interference (RNAi) nanomedicine revolutionizes treatment regimens for ischemic heart diseases by enabling tailored, sequence‐anchored gene regulation. This review highlights the recent advances in nanotechnology‐driven RNAi therapeutics for myocardial ischemia and discusses the key design principles that govern efficient delivery, providing ...
Han Gao, Da Pan, Hélder A. Santos
wiley +1 more source
Detection of PEG-specific antibodies in SARS-CoV-2 positive and negative sera with implications for autoimmune reactivity. [PDF]
Vojdani A, Vojdani E.
europepmc +1 more source
Non‐Functionalized Graphene as an Electrical Sensing Surface for Bacterial Detection
Pathogenic bacteria detection in food remains a major public health concern, driving the need for rapid, cost‐effective, and portable detection systems. This review focuses on the use of non‐functionalized graphene as an electrical sensing surface for bacterial detection, highlighting their unique properties, sensing mechanism, and current developments.
Jazmin Berthe +4 more
wiley +1 more source
Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults. [PDF]
Rudman Spergel AK +22 more
europepmc +1 more source
Here, we present a nanotechnology approach to construct synthetic lipid rafts on the live T cell membrane, leveraging a versatile DNA origami‐enabled platform named as the “cholesterol nano‐patch” (CNP). Our investigation highlights the effectiveness of DNA nanotechnology in exploring the impact of nanoscale arrangement of cholesterols on the ...
Yunmin Jung +4 more
wiley +1 more source
Significance and challenges of immunopharmacogenomics. [PDF]
Hanci Handzha L, Nakamura Y.
europepmc +1 more source
Scalable manufacturing challenges and limited potency remain two of the most intransigent issues limiting clinical translation of EV therapeutics. Mechanical cues can induce phenotypic changes and increased vesiculation in EV source cells without the use of extraneous reagents, chemicals, and/or cargo, thereby potentially drastically improving the ...
Emily H. Powsner +10 more
wiley +1 more source
Mechanism for evolution of diverse autologous antibodies upon broadly neutralizing antibody therapy of people with HIV. [PDF]
Kannan D +4 more
europepmc +1 more source

